Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PUT
Chipotle Mexican Grill
CMG
$43.9B
| $2.63M | ﹤0.01% |
+185,000
| New | +$2.15M |
|
|
NESR
2202
National Energy Services Reunited Corp
NESR
$2.46B
| $2.61M | ﹤0.01% |
+249,913
| New | +$2.21M |
|
2203
Descartes Systems
DSGX
$6.68B
| $2.61M | ﹤0.01% |
71,755
+22,570
| +46% | +$730K |
|
|
FOMX
2204
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.61M | ﹤0.01% |
695,489
-357,252
| -34% | -$1.34M |
|
|
EXAS
2205
PUT
DELISTED
Exact Sciences
EXAS
| $2.6M | ﹤0.01% |
+30,000
| New | +$2.55M |
|
|
KBAL
2206
DELISTED
Kimball International
KBAL
| $2.6M | ﹤0.01% |
183,681
+110,954
| +153% | +$1.66M |
|
|
QIWI
2207
DELISTED
QIWI PLC
QIWI
| $2.59M | ﹤0.01% |
180,215
-93,344
| -34% | -$1.37M |
|
2208
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $2.59M | ﹤0.01% |
103,160
+84,268
| +446% | +$2.1M |
|
|
BCPC
2209
Balchem Corp
BCPC
$5.26B
| $2.59M | ﹤0.01% |
27,897
+23,517
| +537% | +$2.03M |
|
2210
Cognex
CGNX
$9.62B
| $2.59M | ﹤0.01% |
50,888
+25,282
| +99% | +$1.21M |
|
2211
Herbalife
HLF
$1.3B
| $2.59M | ﹤0.01% |
48,809
-90,249
| -65% | -$5.18M |
|
2212
Ambarella
AMBA
$3.04B
| $2.58M | ﹤0.01% |
59,802
+44,086
| +281% | +$1.74M |
|
2213
Skywest
SKYW
$4.35B
| $2.58M | ﹤0.01% |
47,519
+41,710
| +718% | +$2.14M |
|
|
SEI
2214
Solaris Energy Infrastructure
SEI
$2.66B
| $2.58M | ﹤0.01% |
156,750
+141,650
| +938% | +$2.17M |
|
|
TIGR
2215
UP Fintech Holding
TIGR
$856M
| $2.58M | ﹤0.01% |
+199,100
| New | +$2.33M |
|
|
CMCM
2216
Cheetah Mobile
CMCM
$87.2M
| $2.57M | ﹤0.01% |
80,182
-6,879
| -8% | -$234K |
|
2217
LifeVantage
LFVN
$80.1M
| $2.57M | ﹤0.01% |
+180,003
| New | +$2.61M |
|
|
TIVO
2218
DELISTED
Tivo Inc
TIVO
| $2.57M | ﹤0.01% |
275,832
-11,655
| -4% | -$121K |
|
|
NEBUU
2219
DELISTED
Nebula Acquisition Corporation Unit
NEBUU
| $2.56M | ﹤0.01% |
250,000
| – | – |
|
2220
ProQR Therapeutics
PRQR
$244M
| $2.56M | ﹤0.01% |
184,466
+93,968
| +104% | +$1.4M |
|
2221
Scotiabank
BNS
$105B
| $2.56M | ﹤0.01% |
48,002
-115,065
| -71% | -$6.3M |
|
|
NUVA
2222
DELISTED
NuVasive, Inc.
NUVA
| $2.56M | ﹤0.01% |
44,998
-285,011
| -86% | -$15.1M |
|
2223
PUT
Axsome Therapeutics
AXSM
$11.7B
| $2.55M | ﹤0.01% |
+179,500
| New | +$1.67M |
|
2224
CTS Corp
CTS
$1.76B
| $2.55M | ﹤0.01% |
86,705
+74,748
| +625% | +$2.19M |
|
|
PTLA
2225
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.54M | ﹤0.01% |
+73,172
| New | +$2.11M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.